The Mesothelioma Center News
Study: Mesothelioma Survival Rates Rise with SMART Protocol
- by Tim Povtak
- Research & Clinical Trials
- Jan 21, 2021
Using accelerated high-dose radiation prior to surgery produced an unprecedented 65.9-month median survival for a cohort of pleural mesothelioma patients who were part of a larger clinical trial at…
Read More
Thoracic Chemotherapy May Advance Mesothelioma Treatment
- by Tim Povtak
- Treatment & Doctors
- Jan 19, 2021
Thoracic surgeon Dr. Marcello Migliore is convinced that adding hyperthermic intrathoracic chemotherapy to aggressive surgery can extend survival significantly for patients with pleural mesothelioma cancer. He wants others to…
Read More
Statins May Give Boost to Mesothelioma Immunotherapy Drugs
- by Tim Povtak
- Research & Clinical Trials
- Jan 7, 2021
Researchers in Europe may have found the key to making immunotherapy drugs such as Opdivo and Keytruda more effective for a larger percentage of patients with malignant pleural mesothelioma.
Read More
EPA Evaluation Finds Asbestos Still An Unreasonable Risk
- by Tim Povtak
- Asbestos Exposure & Bans
- Jan 6, 2021
The U.S. Environmental Protection Agency released Part 1 of its Final Risk Evaluation for Asbestos, reaffirming preliminary findings from March that were roundly criticized for underestimating the dangers of…
Read More
Judge Rules EPA Must Tighten Asbestos Data Collection
- by Tim Povtak
- Legislation & Litigation
- Dec 23, 2020
United States District Judge Edward Chen has ordered the Environmental Protection Agency to improve its data collection on the amount of asbestos and asbestos products that are coming…
Read More
Top 10 Mesothelioma and Asbestos News Stories of 2020
- by Tim Povtak
- Asbestos Exposure & Bans
- Dec 15, 2020
Growing allegations of asbestos-contaminated talc in various consumer products, coupled with historic approval of a new treatment for pleural mesothelioma, made 2020 a year filled with both anxiety and…
Read More
Study: Immunotherapy Vaccine for Mesothelioma Still Promising
- by Tim Povtak
- Research & Clinical Trials
- Dec 3, 2020
The ONCOS-102 immunotherapy vaccine continues its move toward future, first-line standard of care treatment for malignant pleural mesothelioma, based upon the latest study follow-up data. When combined with standard…
Read More
Mesothelioma Patient Research Expanding in United Kingdom
- by Tim Povtak
- Research & Clinical Trials
- Nov 30, 2020
The University of Sheffield has launched the Mesothelioma UK Research Centre-Sheffield, the country’s first experience-based program designed to improve the treatment and care of patients diagnosed with this aggressive,…
Read More
Mesothelioma Surgery with Organ Removal Extends Survival
- by Tim Povtak
- Treatment & Doctors
- Nov 17, 2020
Removing major organs to achieve a more complete cancer resection did not increase severe complications or hinder survival benefits of aggressive surgery for patients with peritoneal mesothelioma, according to…
Read More
Latest T-Cell Clinical Trial Opens for Mesothelioma Patients
- by Tim Povtak
- Research & Clinical Trials
- Oct 8, 2020
Memorial Sloan Kettering Cancer Center in New York City has begun recruiting patients with pleural mesothelioma for its latest — and potentially most promising — clinical trial involving T-cell…
Read More
